Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | Ms. Susan WilkersonSVP of Global Sales & Services | -15,51k | 1,08M | Vendita | 69,56 | 27,47k | -36,08% |
| 2026-06-09 | Dr. Adrian DevasahayamSVP of Product Line Management | -10,00k | 650,00k | Vendita | 65,00 | 85,12k | -10,51% |
| 2026-06-09 | Mr. Gordon B. HunterIndependent Director | -16,97k | 1,17M | Vendita | 68,80 | 11,24k | -60,17% |
| 2026-06-04 | Mr. Gordon B. HunterIndependent Director | -6,75k | 430,64k | Vendita | 63,78 | 28,21k | -19,31% |
| 2026-06-02 | Dr. William John MillerCEO & Director | -50,00k | 2,93M | Vendita | 58,62 | 369,57k | -11,92% |
| 2026-05-26 | Mr. Gordon B. HunterIndependent Director | -17,71k | 1,09M | Vendita | 61,61 | 34,96k | -33,63% |
| 2026-05-26 | Ms. Susan WilkersonSVP of Global Sales & Services | -35,72k | 2,20M | Vendita | 61,69 | 42,97k | -45,39% |
| 2026-05-26 | Dr. Adrian DevasahayamSVP of Product Line Management | -5,41k | 334,37k | Vendita | 61,84 | 95,12k | -5,38% |
| 2026-05-14 | Mr. Richard A. D’AmoreIndependent Chairman | -43,70k | 2,65M | Vendita | 60,71 | 112,59k | -27,96% |
| 2026-05-12 | Mr. Gordon B. HunterIndependent Director | -29,53k | 1,75M | Vendita | 59,41 | 52,68k | -35,92% |
| 2026-05-11 | Mr. Thomas St. DennisIndependent Director | -1,40k | 86,70k | Vendita | 61,93 | 61,70k | -2,22% |
| 2026-05-07 | Dr. William John MillerCEO & Director | -100,00k | 5,96M | Vendita | 59,55 | 419,57k | -19,25% |
| 2026-05-08 | Ms. Mary Jane RaymondIndependent Director | -1.000,00 | 0,00 | Other Disposition | - | 28,97k | -3,34% |
| 2026-05-08 | Mr. Gordon B. HunterIndependent Director | -7,75k | 455,15k | Vendita | 58,76 | 82,21k | -8,61% |
| 2026-03-20 | Dr. William John MillerCEO & Director | 79,10k | 0,00 | Derivative Exercise and Retained Stock | - | 687,57k | 13,00% |
| 2026-03-20 | Dr. William John MillerCEO & Director | -61,05k | 1,89M | Derivative Exercise and Sale | 31,00 | 687,57k | - |
| 2026-03-20 | Mr. John P. KiernanSenior VP & CFO | -15,05k | 466,52k | Derivative Exercise and Sale | 31,00 | 146,30k | - |
| 2026-03-20 | Mr. John P. KiernanSenior VP & CFO | 15,23k | 0,00 | Derivative Exercise and Retained Stock | - | 146,30k | 11,62% |
| 2026-03-20 | Dr. Adrian DevasahayamSVP of Product Line Management | -10,14k | 314,46k | Derivative Exercise and Sale | 31,00 | 132,52k | - |
| 2026-03-20 | Dr. Adrian DevasahayamSVP of Product Line Management | 16,77k | 0,00 | Derivative Exercise and Retained Stock | - | 132,52k | 14,48% |
| 2026-03-20 | Dr. Peter PorshnevSVP of Unified Engineering | -11,40k | 353,31k | Derivative Exercise and Sale | 31,00 | 195,06k | - |
| 2026-03-20 | Dr. Peter PorshnevSVP of Unified Engineering | 15,51k | 0,00 | Derivative Exercise and Retained Stock | - | 195,06k | 8,64% |
| 2026-03-20 | Ms. Susan WilkersonSVP of Global Sales & Services | -7,00k | 216,88k | Derivative Exercise and Sale | 31,00 | 110,70k | - |
| 2026-03-20 | Ms. Susan WilkersonSVP of Global Sales & Services | 19,91k | 0,00 | Derivative Exercise and Retained Stock | - | 110,70k | 21,94% |
| 2026-03-13 | Dr. Adrian DevasahayamSVP of Product Line Management | 5,11k | 0,00 | Derivative Exercise and Retained Stock | - | 115,38k | 4,64% |
| 2026-03-13 | Dr. Adrian DevasahayamSVP of Product Line Management | -3,15k | 98,18k | Derivative Exercise and Sale | 30,95 - 31,46 | 115,38k | - |
| 2026-03-13 | Dr. William John MillerCEO & Director | 25,92k | 0,00 | Derivative Exercise and Retained Stock | - | 608,47k | 4,45% |
| 2026-03-13 | Dr. William John MillerCEO & Director | -20,16k | 627,27k | Derivative Exercise and Sale | 30,95 - 31,46 | 608,47k | - |
| 2026-03-13 | Ms. Susan WilkersonSVP of Global Sales & Services | 6,08k | 0,00 | Derivative Exercise and Retained Stock | - | 90,23k | 7,22% |
| 2026-03-13 | Ms. Susan WilkersonSVP of Global Sales & Services | -2,19k | 68,14k | Derivative Exercise and Sale | 30,95 - 31,46 | 90,23k | - |
| 2026-03-13 | Dr. Peter PorshnevSVP of Unified Engineering | 4,60k | 0,00 | Derivative Exercise and Retained Stock | - | 178,95k | 2,64% |
| 2026-03-13 | Dr. Peter PorshnevSVP of Unified Engineering | -3,67k | 114,17k | Derivative Exercise and Sale | 30,95 - 31,46 | 178,95k | - |
| 2026-03-13 | Mr. John P. KiernanSenior VP & CFO | 5,90k | 0,00 | Derivative Exercise and Retained Stock | - | 131,08k | 4,71% |
| 2026-03-13 | Mr. John P. KiernanSenior VP & CFO | -6,00k | 186,64k | Derivative Exercise and Sale | 30,95 - 31,46 | 131,08k | - |
| 2026-03-03 | Dr. William John MillerCEO & Director | -50,00k | 1,58M | Vendita | 31,24 - 32,00 | 414,54k | -10,76% |
| 2025-12-10 | Ms. Susan WilkersonSVP of Global Sales & Services | -33,00k | 1,05M | Vendita | 31,88 | 52,16k | -38,75% |
| 2025-12-05 | Dr. William John MillerCEO & Director | -25,00k | 800,00k | Vendita | 32,00 | 464,54k | -5,11% |
| 2025-12-02 | Dr. William John MillerCEO & Director | -25,00k | 727,50k | Vendita | 29,10 | 489,54k | -4,86% |
| 2025-10-02 | Dr. Adrian DevasahayamSVP of Product Line Management | -3,85k | 130,93k | Vendita | 34,00 | 78,27k | -4,69% |
| 2025-10-01 | Dr. William John MillerCEO & Director | -25,00k | 800,00k | Vendita | 32,00 | 514,54k | -4,63% |
| 2025-09-23 | Dr. Adrian DevasahayamSVP of Product Line Management | -4,01k | 120,42k | Vendita | 30,00 | 82,12k | -4,66% |
| 2025-09-15 | Dr. Adrian DevasahayamSVP of Product Line Management | -4,05k | 105,20k | Vendita | 26,00 | 86,13k | -4,49% |
| 2025-09-09 | Dr. William John MillerCEO & Director | -25,00k | 625,00k | Vendita | 25,00 | 539,54k | -4,43% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
